Suppr超能文献

印度北部终末期肾病患者群体中的杀伤细胞免疫球蛋白样受体基因分布。

Distribution of Killer cell immunoglobulin like receptor genes in end stage renal disease among North Indian population.

机构信息

Department of Medical Genetics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India; School of Biotechnology, KIIT University, Bhubaneswar, India.

出版信息

Hum Immunol. 2013 Oct;74(10):1339-45. doi: 10.1016/j.humimm.2013.06.015. Epub 2013 Jun 15.

Abstract

INTRODUCTION

NK cell function is regulated by cell surface inhibitory and activating receptors including the C-type lectin receptors and Killer Immunoglobulin-like receptors (KIR). The effect of immune modulating cytokines produced by NK cells in the pathogenesis of end stage renal disease (ESRD) remained intriguing. In this regard the present study assesses the combinatorial association of KIR gene content and KIR receptor-HLA ligand in the North Indian ESRD patients.

MATERIAL AND METHODS

KIR gene polymorphism as a susceptible marker in ESRD among 512 patients and 512 ethnically matched controls was analyzed. PCR-SSP based genotyping for KIR gene content and HLA-A, B, C typing was carried out.

RESULTS

Significant difference in frequencies of KIR2DS1-HLA-C2 (p≤0.0001, OR=1.98, CI=1.50-2.61), KIR2DS2-HLAC1 (p≤0.0001, OR=1.87, CI=1.42-2.46), KIR3DS1-HLA-Bw4 (p=0.0038, OR=1.46, CI=1.13-1.88) combinations for ESRD was found. In the combinatorial analysis Bw4(+)/3DL1(-)/3DS1(+) (p≤0.0001, OR=4.90, CI=2.75-8.71) and C1(+)/2DL2(-)/2DL3(-)/2DS2(+)/2DS3(+) (p=0.0037, OR=2.50, CI=1.35-4.63) showed risk association. KIR3DS1 was observed to be susceptible for all four primary kidney disease groups.

CONCLUSION

NK cell de-regulation due to HLA ligand binding KIR receptors may be involved in the patho-physiology of ESRD. Upon analyzing the data in this context it was found that C2/C2 donor might improve the clinical outcome of patients having C2 ligands.

摘要

介绍

NK 细胞的功能受细胞表面抑制和激活受体的调节,包括 C 型凝集素受体和杀伤免疫球蛋白样受体(KIR)。NK 细胞产生的免疫调节细胞因子在终末期肾病(ESRD)发病机制中的作用仍然很有趣。在这方面,本研究评估了 KIR 基因含量和 KIR 受体-HLA 配体在北印度 ESRD 患者中的组合关联。

材料和方法

在 512 名患者和 512 名种族匹配的对照中,分析了 KIR 基因多态性作为 ESRD 的易感标志物。进行了基于 PCR-SSP 的 KIR 基因含量和 HLA-A、B、C 型基因分型。

结果

发现 ESRD 患者中 KIR2DS1-HLA-C2(p≤0.0001,OR=1.98,CI=1.50-2.61)、KIR2DS2-HLAC1(p≤0.0001,OR=1.87,CI=1.42-2.46)、KIR3DS1-HLA-Bw4(p=0.0038,OR=1.46,CI=1.13-1.88)组合的频率存在显著差异。在组合分析中,Bw4(+)/3DL1(-)/3DS1(+)(p≤0.0001,OR=4.90,CI=2.75-8.71)和 C1(+)/2DL2(-)/2DL3(-)/2DS2(+)/2DS3(+)(p=0.0037,OR=2.50,CI=1.35-4.63)显示出风险关联。观察到 KIR3DS1 对所有四种原发性肾病组均易感。

结论

由于 HLA 配体结合 KIR 受体导致的 NK 细胞失调可能参与了 ESRD 的病理生理学过程。在这种情况下分析数据时,发现 C2/C2 供体可能会改善具有 C2 配体的患者的临床结局。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验